Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Charmacy Pharmaceutical Co., Ltd. Class H (2289) Stock Price & Analysis

0 Followers

2289 Stock Chart & Stats

HK$5.49HK$0.00(0.00%)
At close: 4:00 PM GMT+8
HK$5.49HK$5.495HK$5.5Aug 24Sep 9Oct 23
Day’s Range
HKD 5.49 - HKD 5.49
52-Week Range
HKD 4.30 - HKD 8.00
Previous Close
HKD 5.49
Volume
N/A
Average Volume (3M)
1,667
Market Cap
HKD 592.92M
Enterprise Value
HKD 2.75B
Total Cash (Recent Filing)
HKD 530.00M
Total Debt (Recent Filing)
HKD 2.09B
Price to Earnings (P/E)
10.9
Beta
-0.26
Next Earnings
Mar 26, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
May 27, 2026
Dividend Yield
6.26%

Bulls Say, Bears Say

Bulls Say

Stable Revenue Base

Revenue remained relatively stable and increased 3.33% in 2025 after being roughly flat in 2024. This provides an established sales base and indicates modest ongoing demand, supporting continued operating activity and a foundation for further growth over the next several quarters.

Improving Gross Margin

The rise in gross margin from approximately 5.95% in 2020 to 7.66% in 2025 shows improved economics on revenue generated. If maintained, this structural progress can support stronger gross-profit generation and provide some protection against pressure on downstream earnings.

Strong 2025 Free Cash Flow

Free cash flow reached approximately 263M in 2025 and was broadly aligned with net income, with a free-cash-flow-to-net-income ratio near 0.97. This supports the quality of reported earnings and gives the company internally generated cash to fund operations and financial commitments.

Bears Say

Rising Balance-Sheet Leverage

Debt increased materially while equity remained fairly flat, pushing debt-to-equity from about 2.74 to 3.39. This indicates that balance-sheet expansion is increasingly debt funded, raising financial risk and reducing flexibility to absorb weaker earnings or fund future needs.

Thin And Declining Net Profitability

Net margin remains very thin at approximately 1.06% and has declined substantially from 2.17% in 2022, while net income also fell in 2025. Limited earnings conversion leaves less room to withstand operating pressure and makes returns more sensitive to small changes in costs or revenue.

Volatile Operating Cash Flow

Although cash generation improved in 2025, operating cash flow has varied from negative in 2023 to positive in later years, and free-cash-flow growth was slightly negative in 2025. This volatility reduces confidence that strong cash conversion can be sustained consistently.

Charmacy Pharmaceutical Co., Ltd. Class H News

2289 FAQ

What was Charmacy Pharmaceutical Co., Ltd. Class H’s price range in the past 12 months?
Charmacy Pharmaceutical Co., Ltd. Class H lowest stock price was HK$4.30 and its highest was HK$8.00 in the past 12 months.
What is Charmacy Pharmaceutical Co., Ltd. Class H’s market cap?
Charmacy Pharmaceutical Co., Ltd. Class H’s market cap is HK$592.92M.
When is Charmacy Pharmaceutical Co., Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Charmacy Pharmaceutical Co., Ltd. Class H’s earnings last quarter?
Charmacy Pharmaceutical Co., Ltd. Class H released its earnings results on Aug 31, 2026. The company reported HK$0.238 earnings per share for the quarter.
Is Charmacy Pharmaceutical Co., Ltd. Class H overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Charmacy Pharmaceutical Co., Ltd. Class H pay dividends?
Charmacy Pharmaceutical Co., Ltd. Class H pays a Annually dividend of HK$0.344 which represents an annual dividend yield of 6.26%. See more information on Charmacy Pharmaceutical Co., Ltd. Class H dividends here
What is Charmacy Pharmaceutical Co., Ltd. Class H’s EPS estimate?
Charmacy Pharmaceutical Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Charmacy Pharmaceutical Co., Ltd. Class H have?
Charmacy Pharmaceutical Co., Ltd. Class H has 108,000,000 shares outstanding.
What happened to Charmacy Pharmaceutical Co., Ltd. Class H’s price movement after its last earnings report?
Charmacy Pharmaceutical Co., Ltd. Class H reported an EPS of HK$0.238 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Charmacy Pharmaceutical Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2289
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology